Reference health

A comparative pilot study of oral diacerein and locally treated diacerein-loaded nanoparticles in a model of osteoarthritis

https://doi.org/10.1016/j.ijpharm.2020.119249
CiteStamped reference-health badge
1 of 41 checkable references need attention · checked 2026-07-22

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

4 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted — notice via Crossref, record curated by Retraction Watch10.1002/art.23056
<i>Retracted:</i> The efficacy and safety of diacerein in the treatment of painful osteoarthritis of the knee: A randomized, multicenter, double‐blind, placebo‐controlled study with primary end points at two months after the end of a three‐month treatment period
The 40 checked references that resolve
resolves10.1016/j.jddst.2019.101206
Doxorubicin-verapamil dual loaded PLGA nanoparticles for overcoming P-glycoprotein mediated resistance in cancer: Effect of verapamil concentration
resolves10.1016/j.semarthrit.2018.01.009
Efficacy and safety of repeated courses of hyaluronic acid injections for knee osteoarthritis: A systematic review
resolves10.1093/rheumatology/ken116
Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes
resolves10.1007/BF00301004
Reduction of tumor necrosis factor ? and interleukin-1? levels in human synovial tissue by interleukin-4 and glucocorticoid
resolves10.23736/S1973-9087.19.05633-8
Appropriateness of clinical criteria for the use of SYmptomatic Slow-Acting Drug for OsteoArthritis (SYSADOA). A Delphi Method Consensus initiative among experts in Italy
resolves10.1016/j.phrs.2008.11.004
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy
resolves10.1186/ar2444
Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling
resolves10.1172/JCI112350
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.
resolves10.1016/S0140-6736(05)71086-2
Pathogenesis and management of pain in osteoarthritis
resolves10.2165/00002512-200522020-00005
Disease-Modifying Therapies for Osteoarthritis
resolves10.1007/s11926-001-0061-y
Diacerein as a disease-modulating agent in osteoarthritis
resolves10.2165/00002018-199005030-00005
Intra-Articular Steroid Injection A Risk-Benefit Assessment
resolves10.1093/rheumatology/kex496
Current status and future prospects for disease modification in osteoarthritis
resolves10.1053/joca.2001.0509
Characterization of infiltrating T cells and Th1/Th2-type cytokines in the synovium of patients with osteoarthritis
resolves10.1002/jor.21079
Effect of pro‐inflammatory and immunoregulatory cytokines on human tenocytes
resolves10.1007/s13770-018-0119-9
In Vitro Anti-Inflammation and Chondrogenic Differentiation Effects of Inclusion Nanocomplexes of Hyaluronic Acid-Beta Cyclodextrin and Simvastatin
resolves10.1136/ard.50.6.395
Interleukin-1, immune activation pathways, and different mechanisms in osteoarthritis and rheumatoid arthritis.
resolves10.1093/bmb/lds038
Epidemiology and burden of osteoarthritis
resolves10.1016/j.joca.2007.02.021
The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study
resolves10.1002/art.1780350507
The interleukin‐1 receptor in normal and osteoarthritic human articular chondrocytes. Identification as the type I receptor and analysis of binding kinetics and biologic function
resolves10.1177/1759720X09359104
Effects of diacerein at the molecular level in the osteoarthritis disease process
resolves10.1001/jama.2017.5283
Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis
resolves10.1007/s100670070029
Significance of Low mRNA Levels of Interleukin-4 and -10 in Mononuclear Cells of the Synovial Fluid of Patients with Rheumatoid Arthritis
resolves10.1146/annurev.me.38.020187.002221
ENDOTOXINS AND DISEASE MECHANISMS
resolves10.1001/jama.286.8.954
Risk of Cardiovascular Events Associated With Selective COX-2 Inhibitors
resolves10.1016/S0174-173X(86)80005-X
Characterization of a Specific Antiserum to Rabbit Stromelysin and Demonstration of the Synthesis of Collagenase and Stromelysin by Stimulated Rabbit Articular Chondrocytes
resolves10.2165/00003088-199835050-00002
Clinical Pharmacokinetics of Diacerein
resolves10.1007/s40264-015-0266-z
Benefit–Risk Assessment of Diacerein in the Treatment of Osteoarthritis
resolves10.1007/s40266-016-0347-4
Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
resolves10.1002/1529-0131(200010)43:10<2339::AID-ANR23>3.0.CO;2-P
Efficacy and safety of diacerein in osteoarthritis of the knee: A double-blind, placebo-controlled trial
resolves10.1016/j.joca.2005.07.014
Osteoarthritis cartilage histopathology: grading and staging
resolves10.2174/1381612821666150901100247
Particulate Systems Based on Poly(Lactic-co-Glycolic)Acid (pLGA) for Immunotherapy of Cancer
resolves10.1007/s11095-015-1748-5
PLGA-Based Nanoparticles: a Safe and Suitable Delivery Platform for Osteoarticular Pathologies
resolves10.1136/annrheumdis-2016-210815
EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis
resolves10.1016/S0006-2952(02)01485-5
Effects of rhein on human articular chondrocytes in alginate beads
resolves10.1016/j.msec.2016.04.062
The use of nanomaterials to treat bone infections
resolves10.1100/2012/310745
Combined Effect of Subchondral Drilling and Hyaluronic Acid with/without Diacerein in Full-Thickness Articular Cartilage Lesion in Rabbits
resolves10.1016/j.joca.2013.05.018
Localized 3D analysis of cartilage composition and morphology in small animal models of joint degeneration
resolves10.1016/j.joca.2012.04.002
IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage
The 4 references without a DOI — listed, not checked
no DOI — not checkedVariability in the prescription of drugs with uncertain effectiveness. The case of SYSADOA in the Basque Country. GMS
no DOI — not checkedRhein, a diacerhein-derived metabolite, modulates the expression of matrix degrading enzymes and the cell proliferation of articular chondrocytes by inhibiting ERK and JNK-AP-1 dependent pathways
no DOI — not checked10.1016/j.ijpharm.2020.119249_b0145
no DOI — not checkedCurcumin-loaded poly lactic-co-glycolic acid nanoparticles effects on mono-iodoacetate -induced osteoarthritis in rats
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.ijpharm.2020.119249"><img src="https://citestamp.com/citestamped/10.1016/j.ijpharm.2020.119249/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.ijpharm.2020.119249/badge.svg)](https://citestamp.com/citestamped/10.1016/j.ijpharm.2020.119249)